Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 20,104 | 21,146 | 23,795 | 19,552 | 21,762 |
| Cost of Goods | 9,569 | 9,838 | 12,413 | 10,068 | 11,134 |
| Gross Profit | 10,535 | 11,308 | 11,382 | 9,484 | 10,628 |
| Operating Expenses | 36,492 | 24,642 | 36,439 | 42,490 | 36,459 |
| Operating Income | -25,388 | -12,496 | -24,644 | -32,938 | -25,697 |
| Interest Expense | 0 | 0 | 16 | 10 | 0 |
| Other Income | 3,953 | -2,119 | 2,629 | 48 | 7,415 |
| Pre-tax Income | -21,435 | -14,615 | -22,031 | -32,900 | -18,282 |
| Income Tax | 90 | 11 | -35,932 | -1,216 | -609 |
| Net Income Continuous | -21,525 | -14,626 | 13,901 | -31,684 | -17,673 |
| Net Income Discontinuous | -5,233 | 141,694 | 5,382 | -3,003 | -15,786 |
| Net Income | $-26,758 | $127,068 | $19,283 | $-34,687 | $-33,459 |
| EPS Basic Total Ops | -0.07 | 0.33 | 0.05 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.06 | -0.04 | 0.04 | -0.08 | -0.05 |
| EPS Basic Discontinuous Ops | -0.01 | 0.37 | 0.02 | -0.01 | -0.04 |
| EPS Diluted Total Ops | -0.07 | 0.33 | 0.05 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | 0.04 | -0.08 | -0.05 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.37 | 0.02 | -0.01 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.03 | 0.05 | -0.06 | -0.05 |
| EBITDA(a) | $-25,322 | $-11,720 | $-23,815 | $-32,028 | $-22,433 |